Answers are grounded in this paper and cite their sources.
-targeting siRNAs. The optimization strategy here provides a framework for the chemical optimization of siRNAs for PE as well as other targets and clinical indications.
No takes yet. Share an insight, caveat, or question.
Davis et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: